A major Indian biotechnology company just announced it is breaking into the exciting field of biologic medicines. Zydus-Cadila has successfully manufactured a rough copy of a popular autoimmune disease biologic called Humira. The firm has about two dozen other biologic products under development.
Roger Bate | All Articles
Things just keep getting worse for India’s generic drug companies in America. Dr Reddy’s Laboratories, an Indian generic drug manufacturer, has withdrawn 13,560 bottles of generic Toprol, a blood pressure medicine, from the U.S. market due to solubility problems. The news comes hot on the heels of a recall just weeks ago by Wockhardt Ltd, another Indian producer, which withdrew 109,744 bottles of the same drug -- and for the same reason.
This election season has made victims of us all. To hear it from Republicans, Medicare subscribers are targets of raids. Sit with Democrats long enough and privileged women become casualties of war. In reality these people are hardly victims, and America’s election machine distracts from the needs of the truly poor and oppressed. Today, malaria will massacre thousands of poor African children. For millions more, their only protection is a drug, a bed net, or a protective spray provided by the U.S. government.
Last week, the Prescription Drug User Fee Act (PDUFA) passed reauthorization in the Senate, but not before an amendment offered by Senator John McCain (R-AZ) lost quite narrowly (43-54). McCain wanted to allow Americans with poor insurance coverage to personally import medicines from credentialed foreign pharmacies --- a move opposed by U.S. pharmacists and drug makers. Hundreds of thousands of underinsured Americans currently buy medicine online from overseas sellers, sometimes at significant risk. The McCain amendment would have helped them buy medicine more safely.